Literature DB >> 1452334

Complement and antibody participation in opsonophagocytosis of type IV and V group B streptococci.

M A Hall1, M S Edwards, C J Baker.   

Abstract

Requirements for complement and antibody in neutrophil-mediated killing of serotype IV and V group B streptococci were investigated. Neutrophils from adults were tested in an opsonophagocytic assay with sera from healthy adults, healthy newborns, and hypogammaglobulinemic, agammaglobulinemic, and C4-deficient patients. For all serum sources, the bactericidal index for both serotypes exceeded 84% after 40 min of incubation. Heat inactivation of sera ablated killing. Blockade of neutrophil receptor FcIII effected a maximum of 16% inhibition of opsonophagocytosis, and FcII receptor blockade demonstrated negligible inhibition. When neutrophil complement receptor 1 or 3 blockade was employed, the maximum inhibition detected was 26%. Simultaneous blockade of complement receptors 1 and 3 effected maximum inhibition levels of 25 and 65% for serotypes IV and V, respectively. Blockade of complement receptor 3 and neutrophil receptor FcIII inhibited opsonophagocytosis by 56% for both serotypes. When serum complement concentrations were restricted, neutrophil-mediated killing diminished but was restored by the addition of hyperimmune rabbit antiserum. These findings suggest that complement and antibody are major participants in the opsonophagocytosis of serotypes IV and V group B streptococci. A low prevalence of carriage or mediation of efficient phagocytosis by interactions of neutrophil complement and Fc receptors may contribute to the rarity of human infections caused by these two serotypes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452334      PMCID: PMC258273          DOI: 10.1128/iai.60.12.5030-5035.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  New serotypes of group B streptococci isolated from human sources.

Authors:  B Perch; E Kjems
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

2.  Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V.

Authors:  J Jelínková; J Motlová
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

3.  Nontypable group B streptococci isolated from human sources.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

4.  ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes.

Authors:  B M Gray
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

5.  Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide.

Authors:  M R Wessels; J L DiFabio; V J Benedì; D L Kasper; F Michon; J R Brisson; J Jelínková; H J Jennings
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

6.  Variation in the group-specific carbohydrate of group A streptococci. I. Immunochemical studies on the carbohydrates of variant strains.

Authors:  M McCARTY; R C LANCEFIELD
Journal:  J Exp Med       Date:  1955-07-01       Impact factor: 14.307

7.  Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies.

Authors:  D C Anderson; L J Miller; F C Schmalstieg; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

8.  Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.

Authors:  D C Anderson; B J Hughes; C W Smith
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.

Authors:  M R Wessels; W J Benedí; H J Jennings; F Michon; J L DiFabio; D L Kasper
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Quantitative determination in human sera of vaccine-induced antibody to type-specific polysaccharides of group B streptococci using an enzyme-linked immunosorbent assay.

Authors:  T K Eisenstein; B J De Cueninck; D Resavy; G D Shockman; R B Carey; R M Swenson
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

View more
  7 in total

1.  Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines.

Authors:  Morven S Edwards; Heidi J Lane; Sharon L Hillier; Marcia A Rench; Carol J Baker
Journal:  Vaccine       Date:  2012-04-24       Impact factor: 3.641

2.  Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.

Authors:  Jenny Herbert; Stephen Thomas; Charlotte Brookes; Claudia Turner; Paul Turner; Francois Nosten; Kirsty Le Doare; Michael Hudson; Paul T Heath; Andrew Gorringe; Stephen Taylor
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

3.  Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis.

Authors:  M J Gaglani; C J Baker; M S Edwards
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

4.  Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection.

Authors:  Kirsty Le Doare; Lauren Allen; Beate Kampmann; Paul Trafford Heath; Stephen Taylor; Anneke C Hesseling; Andrew Gorringe; Christine Elizabeth Jones
Journal:  Vaccine       Date:  2014-12-24       Impact factor: 3.641

5.  A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.

Authors:  Anne Cathrine Vestrheim; Anders Moen; Wolfgang Egge-Jacobsen; Leon Reubsaet; Trine Grønhaug Halvorsen; Diane Bryant Bratlie; Berit Smestad Paulsen; Terje Einar Michaelsen
Journal:  Immun Inflamm Dis       Date:  2014-05-22

Review 6.  Increased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible Mechanisms.

Authors:  Nicolas Dauby; Mustapha Chamekh; Pierrette Melin; Amy L Slogrove; Tessa Goetghebuer
Journal:  Front Immunol       Date:  2016-11-16       Impact factor: 7.561

7.  Opsonophagocytic Antibodies to Serotype Ia, Ib, and III Group B Streptococcus among Korean Infants and in Intravenous Immunoglobulin Products.

Authors:  Han Wool Kim; Ji Hyen Lee; Hye Kyung Cho; Hyunju Lee; Ho Seong Seo; Soyoung Lee; Kyung Hyo Kim
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.